Nirsum Laboratories, Inc.

New York, NY Doing business as Nirsum Labs

UEI
JQEHSCRCNRT5
CAGE
7TUC8
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Subcontinent Asian (Asian-Indian) American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
Other NAICS codes in SAM.gov
SAM.gov registration date
Physical address
200 Vesey St, New York, NY 10080, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Select late-stage CMC, non-clinical studies, and quality programs to accelerate NRS-033 towards pivotal studies and… U01DA061643 National Institute on Drug Abuse (NIH) $29,198,325
Development of a novel drug for treating opioid use disorder UH3DA048234 National Institute on Drug Abuse (NIH) $18,326,789
Development of a novel drug for treating opioid use disorder UG3DA048234 National Institute on Drug Abuse (NIH) $6,611,614

Quick answers

Is Nirsum Laboratories, Inc. registered in SAM.gov?

Yes. Nirsum Laboratories, Inc.'s SAM.gov registration is active through January 23, 2027.

What is Nirsum Laboratories, Inc.'s most recent federal award?

Nirsum Laboratories, Inc.'s most recent federal grant award is Select late-stage CMC, non-clinical studies, and quality programs to accelerate NRS-033 towards pivotal studies and… (U01DA061643), from National Institute on Drug Abuse (NIH), on August 1, 2024.

On GovTribe

See Nirsum Laboratories, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login